Clinical trial
Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers
NCT00490945 · Vanda Pharmaceuticals, Industry · Completed
Key facts
| NCT number | NCT00490945 |
|---|---|
| Title | Safety and Efficacy of VEC-162 on Circadian Rhythm in Healthy Adult Volunteers |
| Official title | A Randomized, Double-blind, Placebo-controlled, Multi-center Study of the Effects of VEC-162 on Circadian Rhythm in Healthy Subjects |
| Lead sponsor | Vanda Pharmaceuticals, Industry |
| Status | Completed |
| Phase | Phase 2 |
| Study type | Interventional |
| Conditions | Circadian Rhythm Sleep Disorders |
| Intervention type | Drug |
| Interventions | VEC-162 |
| Enrollment | 45 |
| Start date | Jul 1, 2004 |
| Primary completion | Mar 1, 2005 |
| Completion | Mar 1, 2005 |
| First posted | Jun 25, 2007 |
| Last update posted | Aug 26, 2014 |
| Countries | United States |
At a glance
- 1–9 Study sites
- Yes Results posted
- None Linked FDA submissions
Counts are shown as ranges. Exact figures, trends and every underlying record are available in Orca1.
About ClinicalTrials.gov studies
ClinicalTrials.gov is the U.S. National Library of Medicine's registry of clinical studies conducted around the world. Contact and investigator details are not shown here.
Source: U.S. National Library of Medicine (NLM), ClinicalTrials.gov · Source date: